NCT01463410View on ClinicalTrials.gov

Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler

TerminatedOBSERVATIONAL
Enrollment

264

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

March 31, 2013

Conditions
Acute Myeloid Leukemia (AML)Acute Promyelocytic Leukemia (APL)Refractory Anemia With Excess of Blasts (RAEB)
Trial Locations (5)

10065

Memorial Sloan Kettering Cancer Center, New York

43210

James Cancer Hospital, Columbus

89081

University Hospital Ulm, Ulm

3015 AA

Erasmus Medical Center, Rotterdam

CF144XN

Cardiff University, Cardiff

Sponsors

Collaborators (1)

Illumina, Inc.
All Listed Sponsors
collaborator

Illumina, Inc.

INDUSTRY

lead

Skyline Diagnostics BV

INDUSTRY